Home › Diabetes › Oklahoma
Diabetes clinical trials in Oklahoma
4 studies for Diabetes are looking for participants at sites in Oklahoma.
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Chickasha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07284901INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
- University of Oklahoma Health Sciences Center, Oklahoma City
RecruitingPhase 2
Ages 6 to 17 · All sexes · Updated Aug 13, 2026 · NCT07224321Fiber mHealth Intervention for Prediabetes
- University of Oklahoma Health Campus, Tulsa
Recruiting
Ages 18 to 39 · All sexes · Updated Jun 1, 2026 · NCT07491653Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
- University of Oklahoma Health Sciences Center, Oklahoma City
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Apr 1, 2026 · NCT05174052From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.